Why is going to the pharmacy so miserable these days?

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

CITY

SCIENCE HAD ITS ‘CHRONIC PAIN REVOLUTION.’ SO WHY IS TREATMENT STILL BROKEN, DELAYED AND OUT OF REACH?

Jon Bentley urges a return to good old face-to-face communication to combat rising cybersecurity threats

SPECIAL REPORT

Got a tricky question? Our experts have all the answers, so go ahead and ask us anything…